The blood biomarkers puzzle – A review of protein biomarkers in neurodegenerative diseases
出版年份 2021 全文链接
标题
The blood biomarkers puzzle – A review of protein biomarkers in neurodegenerative diseases
作者
关键词
Neurofilament, Neurologic disease, Biomarker
出版物
JOURNAL OF NEUROSCIENCE METHODS
Volume 361, Issue -, Pages 109281
出版商
Elsevier BV
发表日期
2021-07-06
DOI
10.1016/j.jneumeth.2021.109281
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- MRI Lesion State Modulates the Relationship Between Serum Neurofilament Light and Age in Multiple Sclerosis
- (2021) Mattia Rosso et al. JOURNAL OF NEUROIMAGING
- Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology
- (2021) Nicholas J. Ashton et al. ACTA NEUROPATHOLOGICA
- Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study
- (2021) Alex Iranzo et al. LANCET NEUROLOGY
- Serum neurofilament light in MS: The first true blood-based biomarker?
- (2021) Simon Thebault et al. Multiple Sclerosis Journal
- Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis
- (2021) Robert J Fox et al. Multiple Sclerosis Journal
- Neurological symptoms and blood neurofilament light levels
- (2021) Christian Barro et al. ACTA NEUROLOGICA SCANDINAVICA
- Comparison of Simoa TM and Ella TM to assess serum neurofilament‐light chain in multiple sclerosis
- (2021) Audrey Gauthier et al. Annals of Clinical and Translational Neurology
- CHIT1 at Diagnosis Reflects Long‐Term Multiple Sclerosis Disease Activity
- (2020) Emanuela Oldoni et al. ANNALS OF NEUROLOGY
- Neurofilament light chain and C reactive protein explored as predictors of survival in amyotrophic lateral sclerosis
- (2020) Maxim De Schaepdryver et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
- (2020) Carolin Heller et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Blood neurofilament light levels segregate treatment effects in multiple sclerosis
- (2020) Bénédicte Delcoigne et al. NEUROLOGY
- Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-Synuclein
- (2020) Barkovits et al. Cells
- Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies
- (2020) Marcello Rossi et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype
- (2020) Ione O.C. Woollacott et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Neurofilaments in progressive multiple sclerosis: a systematic review
- (2020) Thomas Williams et al. JOURNAL OF NEUROLOGY
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- Plasma neurofilament light levels are associated with the risk of disability in multiple sclerosis
- (2020) Ali Manouchehrinia et al. NEUROLOGY
- Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice
- (2020) Carlo Wilke et al. EMBO Molecular Medicine
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study
- (2020) Yakeel T Quiroz et al. LANCET NEUROLOGY
- Serum neurofilament light as a biomarker in progressive multiple sclerosis
- (2020) Raju Kapoor et al. NEUROLOGY
- Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
- (2020) Timothy Miller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity
- (2020) Xavier Ayrignac et al. Scientific Reports
- CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis
- (2020) Elizabeth Gray et al. Annals of Clinical and Translational Neurology
- Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study
- (2020) Stefan Bittner et al. EBioMedicine
- Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease
- (2020) David Mengel et al. ANNALS OF NEUROLOGY
- Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. BRAIN
- Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer’s disease
- (2020) Andréa L Benedet et al. BRAIN
- Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring
- (2020) Peter A Calabresi et al. Multiple Sclerosis Journal
- Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s disease
- (2020) Filipe B. Rodrigues et al. Science Translational Medicine
- Chitinases and chitinase-like proteins as biomarkers in neurologic disorders
- (2020) Rucsanda Pinteac et al. Neurology-Neuroimmunology & Neuroinflammation
- Neurofilaments and tau in CSF in an infant with SMA type 1 treated with nusinersen
- (2019) Benedikt Winter et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease
- (2019) Philip S. J. Weston et al. Alzheimers Research & Therapy
- Serum NFL discriminates Parkinson disease from atypical parkinsonisms
- (2019) Tainá M. Marques et al. NEUROLOGY
- Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
- (2019) Jens Kuhle et al. NEUROLOGY
- Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia
- (2019) MHD Rami Al Shweiki et al. JOURNAL OF PSYCHIATRIC RESEARCH
- NFL is a marker of treatment response in children with SMA treated with nusinersen
- (2019) Bob Olsson et al. JOURNAL OF NEUROLOGY
- CSF chitinase proteins in amyotrophic lateral sclerosis
- (2019) Alexander G Thompson et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
- (2019) Kristin N. Varhaug et al. Frontiers in Neurology
- Neurofilament as a potential biomarker for spinal muscular atrophy
- (2019) Basil T. Darras et al. Annals of Clinical and Translational Neurology
- Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches
- (2019) Carlo Wilke et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
- (2019) Suzanne E. Schindler et al. NEUROLOGY
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
- (2019) Claire Bridel et al. JAMA Neurology
- Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status
- (2019) Sebastian Palmqvist et al. JAMA Neurology
- Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis
- (2019) E. Thouvenot et al. EUROPEAN JOURNAL OF NEUROLOGY
- Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD
- (2019) Mitsuru Watanabe et al. NEUROLOGY
- Blood NfL
- (2019) Chin-Hsien Lin et al. NEUROLOGY
- Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
- (2019) Darryl C. De Vivo et al. NEUROMUSCULAR DISORDERS
- Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years
- (2019) Ester Cantó et al. JAMA Neurology
- Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
- (2019) Kjetil Bjornevik et al. JAMA Neurology
- Neurochemical biomarkers in amyotrophic lateral sclerosis
- (2019) Federico Verde et al. CURRENT OPINION IN NEUROLOGY
- Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders
- (2019) Kasper Katisko et al. JOURNAL OF NEUROLOGY
- Flotillin is a Novel Diagnostic Blood Marker of Alzheimer’s Disease
- (2019) Mohammad Abdullah et al. JOURNAL OF ALZHEIMERS DISEASE
- Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
- (2019) Emma L van der Ende et al. LANCET NEUROLOGY
- CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
- (2019) Samir Abu-Rumeileh et al. Alzheimers Research & Therapy
- Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis
- (2018) Alexander G. Thompson et al. ANNALS OF NEUROLOGY
- Neurofilament light: A candidate biomarker of pre-symptomatic ALS and phenoconversion
- (2018) Michael Benatar et al. ANNALS OF NEUROLOGY
- Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
- (2018) Christian Barro et al. BRAIN
- Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain
- (2018) E. Quintana et al. EUROPEAN JOURNAL OF NEUROLOGY
- The Past and the Future of Alzheimer’s Disease Fluid Biomarkers
- (2018) Kaj Blennow et al. JOURNAL OF ALZHEIMERS DISEASE
- Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease
- (2018) L.M. Bekris et al. JOURNAL OF NEUROIMMUNOLOGY
- Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis
- (2018) Irene Håkansson et al. Journal of Neuroinflammation
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Towards a TDP-43-Based Biomarker for ALS and FTLD
- (2018) Emily Feneberg et al. MOLECULAR NEUROBIOLOGY
- Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome
- (2018) Eric Thouvenot et al. Multiple Sclerosis Journal
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Neurofilament light protein in blood predicts regional atrophy in Huntington disease
- (2018) Eileanoir B. Johnson et al. NEUROLOGY
- Multiple Sclerosis: Mechanisms and Immunotherapy
- (2018) Clare Baecher-Allan et al. NEURON
- Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis
- (2018) B. Gille et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
- (2018) Eugenio Mercuri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers
- (2018) Lenka Novakova et al. PLoS One
- Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome
- (2018) Eric Thouvenot et al. Multiple Sclerosis Journal
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase
- (2018) Patrick Oeckl et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- Microglial signatures and their role in health and disease
- (2018) Oleg Butovsky et al. NATURE REVIEWS NEUROSCIENCE
- Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis
- (2018) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum GFAP as a biomarker for disease severity in multiple sclerosis
- (2018) A. Abdelhak et al. Scientific Reports
- Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
- (2018) Piotr Lewczuk et al. Alzheimers Research & Therapy
- Serum Soluble Triggering Receptor Expressed on Myeloid Cells 2 as a Biomarker for Incident Dementia: The Hisayama Study
- (2018) Tomoyuki Ohara et al. ANNALS OF NEUROLOGY
- Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis
- (2018) Federico Verde et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity
- (2018) Heidi Högel et al. Multiple Sclerosis Journal
- Review: Fluid biomarkers for frontotemporal dementias
- (2018) H. Zetterberg et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease
- (2018) Yung-Shuan Lin et al. Scientific Reports
- Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
- (2018) Raquel Sánchez-Valle et al. Alzheimers Research & Therapy
- Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis
- (2018) Tanuja Chitnis et al. Annals of Clinical and Translational Neurology
- Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis
- (2017) I. Håkansson et al. EUROPEAN JOURNAL OF NEUROLOGY
- The clinical landscape for SMA in a new therapeutic era
- (2017) K Talbot et al. GENE THERAPY
- CNS inflammation and neurodegeneration
- (2017) Tanuja Chitnis et al. JOURNAL OF CLINICAL INVESTIGATION
- Quantitative analysis of four protein biomarkers: An automated microfluidic cartridge-based method and its comparison to colorimetric ELISA
- (2017) Mark Dysinger et al. JOURNAL OF IMMUNOLOGICAL METHODS
- BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset
- (2017) M. Puthenparampil et al. Journal of Neuroinflammation
- Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
- (2017) Maxim De Schaepdryver et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
- (2017) Lauren M Byrne et al. LANCET NEUROLOGY
- Fluid biomarker and electrophysiological outcome measures for progressive MS trials
- (2017) Christian Barro et al. Multiple Sclerosis Journal
- Defining active progressive multiple sclerosis
- (2017) Finn Sellebjerg et al. Multiple Sclerosis Journal
- Neurotoxic reactive astrocytes are induced by activated microglia
- (2017) Shane A. Liddelow et al. NATURE
- Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease
- (2017) Joana B. Pereira et al. NEUROBIOLOGY OF AGING
- Serum neurofilament light in familial Alzheimer disease
- (2017) Philip S.J. Weston et al. NEUROLOGY
- Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
- (2017) Brit Mollenhauer et al. NEUROLOGY
- Serum neurofilament is associated with progression of brain atrophy and disability in early MS
- (2017) Jens Kuhle et al. NEUROLOGY
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis
- (2017) Emily Feneberg et al. NEUROLOGY
- Review: Tau in biofluids - relation to pathology, imaging and clinical features
- (2017) H. Zetterberg NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid
- (2017) Mohammad Shahnawaz et al. JAMA Neurology
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Fluid biomarker and electrophysiological outcome measures for progressive MS trials
- (2017) Christian Barro et al. Multiple Sclerosis Journal
- Defining active progressive multiple sclerosis
- (2017) Finn Sellebjerg et al. Multiple Sclerosis Journal
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Tau or neurofilament light—Which is the more suitable biomarker for Huntington’s disease?
- (2017) Valter Niemelä et al. PLoS One
- Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study
- (2017) Yang Hu et al. Scientific Reports
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
- (2016) Laura Piccio et al. ACTA NEUROPATHOLOGICA
- Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
- (2016) Jens Kuhle et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis
- (2016) Lenka Novakova et al. JOURNAL OF NEUROCHEMISTRY
- Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis
- (2016) M.Alba Mañé-Martínez et al. JOURNAL OF NEUROIMMUNOLOGY
- Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum
- (2016) Carlo Wilke et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
- (2016) Amanda Heslegrave et al. Molecular Neurodegeneration
- Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab
- (2016) Pierre de Flon et al. NEUROLOGY
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Neurofilament light chain level is a weak risk factor for the development of MS
- (2016) Georgina Arrambide et al. NEUROLOGY
- Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
- (2016) Mehtap Bacioglu et al. NEURON
- Monocytes of patients with amyotrophic lateral sclerosis linked to gene mutations display altered TDP-43 subcellular distribution
- (2016) G. De Marco et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
- (2016) Graham Fairfoul et al. Annals of Clinical and Translational Neurology
- Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
- (2016) Magnus Gisslén et al. EBioMedicine
- Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis
- (2015) Patrick Weydt et al. ANNALS OF NEUROLOGY
- Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
- (2015) Ester Cantó et al. BRAIN
- Cerebrospinal fluid tau and amyloid-β1-42in patients with dementia
- (2015) Tobias Skillbäck et al. BRAIN
- Use of biomarkers in ALS drug development and clinical trials
- (2015) Nadine Bakkar et al. BRAIN RESEARCH
- Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington’s disease patients
- (2015) Edward J. Wild et al. JOURNAL OF CLINICAL INVESTIGATION
- C-Terminally Truncated Forms of Tau, But Not Full-Length Tau or Its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death
- (2015) D. Kanmert et al. JOURNAL OF NEUROSCIENCE
- Frontotemporal dementia
- (2015) Jee Bang et al. LANCET
- Stability and Reproducibility Underscore Utility of RT-QuIC for Diagnosis of Creutzfeldt-Jakob Disease
- (2015) Maria Cramm et al. MOLECULAR NEUROBIOLOGY
- Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis
- (2015) S Modvig et al. Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis
- (2015) G Hinsinger et al. Multiple Sclerosis Journal
- Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
- (2015) C.-H. Lu et al. NEUROLOGY
- Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
- (2015) J. Kuhle et al. NEUROLOGY
- Amyloid biomarkers in Alzheimer's disease
- (2015) Kaj Blennow et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis
- (2015) S Modvig et al. Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis
- (2015) G Hinsinger et al. Multiple Sclerosis Journal
- Huntington disease
- (2015) Gillian P. Bates et al. Nature Reviews Disease Primers
- Alzheimer's disease
- (2015) Colin L. Masters et al. Nature Reviews Disease Primers
- Emerging Technologies to Increase Ligand Binding Assay Sensitivity
- (2014) Saloumeh K. Fischer et al. AAPS Journal
- Assessing tissue damage in multiple sclerosis: a biomarker approach
- (2014) J. Burman et al. ACTA NEUROLOGICA SCANDINAVICA
- CSF levels of YKL-40 are increased in MS and decrease with immunosuppressive treatment
- (2014) Clas Malmeström et al. JOURNAL OF NEUROIMMUNOLOGY
- N-Acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis
- (2014) Alessandro Trentini et al. JOURNAL OF NEUROLOGY
- Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
- (2014) Erika Assarsson et al. PLoS One
- Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42
- (2014) Sebastian Palmqvist et al. JAMA Neurology
- Controversies and priorities in amyotrophic lateral sclerosis
- (2013) Martin R Turner et al. LANCET NEUROLOGY
- CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions
- (2013) Enrique Alvarez et al. Multiple Sclerosis Journal
- Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
- (2013) Markus Axelsson et al. Multiple Sclerosis Journal
- A comparative study of CSF neurofilament light and heavy chain protein in MS
- (2013) Jens Kuhle et al. Multiple Sclerosis Journal
- Changes in Amyloid- and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein
- (2013) L. F. Maia et al. Science Translational Medicine
- Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS
- (2012) Oleg Butovsky et al. JOURNAL OF CLINICAL INVESTIGATION
- CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis
- (2012) Jeppe Romme Christensen et al. Multiple Sclerosis Journal
- CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
- (2012) M Khalil et al. Multiple Sclerosis Journal
- Phosphorylated -Synuclein in Parkinson's Disease
- (2012) Y. Wang et al. Science Translational Medicine
- Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients
- (2011) Paola Bossù et al. Journal of Neuroinflammation
- Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
- (2011) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis
- (2011) E Cantó et al. Multiple Sclerosis Journal
- Clinical diagnosis and management of amyotrophic lateral sclerosis
- (2011) Orla Hardiman et al. Nature Reviews Neurology
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
- (2010) Manuel Comabella et al. BRAIN
- A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament “hook” effect
- (2010) Ching-Hua Lu et al. JOURNAL OF NEUROSCIENCE METHODS
- Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
- (2010) Mohsen Khademi et al. Multiple Sclerosis Journal
- Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
- (2010) David M Rissin et al. NATURE BIOTECHNOLOGY
- The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
- (2010) Johannes Brettschneider et al. PLoS One
- Astrocytes: biology and pathology
- (2009) Michael V. Sofroniew et al. ACTA NEUROPATHOLOGICA
- Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
- (2009) F. Sellebjerg et al. NEUROLOGY
- Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
- (2009) C. E. Teunissen et al. NEUROLOGY
- Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
- (2008) Lucilla Parnetti et al. BIOLOGICAL PSYCHIATRY
- Protein biomarkers for amyotrophic lateral sclerosis
- (2008) Henrik Ryberg et al. Expert Review of Proteomics
- Biomarkers in amyotrophic lateral sclerosis
- (2008) Martin R Turner et al. LANCET NEUROLOGY
- Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease
- (2008) Radu Constantinescu et al. PARKINSONISM & RELATED DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started